Avineuro

Avineuro is engaged in research and development of original drugs for the treatment of CNS disorders. The main focus of the company is psychiatric and neurological diseases, in particular schizophrenia, anxiety disorders, Parkinson’s disease, and metabolic disorders and obesity.

www.avineuro.ru